Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
To assess the immunogenicity and safety of the vero cell-derived inactivated JE vaccine in Korean healthy children aged 12\~23 months
Epistemonikos ID: 2e892cf59f9566d3a06f794992ceda38562a4184
First added on: May 05, 2024